Cervical Cancer
Cancer
Cervical Cancer is treated with 2 medications in our database, including Keytruda, TIVDAK. 1 of these has manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Merck & Co., Seagen. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Cervical Cancer treatment below.
What help exists for Cervical Cancer
11
drugs indexed
7
with copay cards
7
with patient assistance
0
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Cervical Cancer
11 totalHYCAMTIN
topotecan
ππALYMSYS
bevacizumab-maly
ππJOBEVNE
bevacizumab-nwgd Β· Pharming Healthcare, Inc.
ππTopotecan Hydrochloride
Topotecan Hydrochloride
Zirabev
bevacizumab-bvzr Β· Pfizer
ππMVASI
bevacizumab-awwb Β· Amgen
ππKEYTRUDA QLEX
pembrolizumab and berahyaluronidase alfa-pmph Β· Merck
ππVegzelma
bevacizumab-adcd Β· Celltrion
TIVDAK
tisotumab vedotin
KEYTRUDA
pembrolizumab Β· Merck
ππAvastin
bevacizumab Β· Genentech
π = copay card Β· π = patient assistance program
Prior authorization patterns for Cervical Cancer drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
Showing 10 of 14 PA rules for Cervical Cancer drugs. View individual drug pages for complete PA detail.